Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT03273855 - Fecal microbiota transplantation (FMT) & Adiposity / Obesity

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Study overview

NCT03273855 - Fecal microbiota transplantation (FMT) & Adiposity / Obesity is a randomized, double-blinded and placebo controlled clinical treatment trial studying Fecal microbiota transplantation (FMT) or placebo in 60 randomized patients with Adiposity / Obesity (1)

Primary outcome measures

Change in individual weight loss (kg)

Results

For NCT03273855 - Fecal microbiota transplantation (FMT) & Adiposity / Obesity, as of February 2026 there is no yet publicly available full results article, but the protocol is published and the trial has completed follow‑up

References

(1) Hanssen et al. 2023 BMJ Open 13(12): e073242

…

References (Sources)

Randomised, placebo-controlled, double-blinded trial of fecal microbiota transplantation in severe obesity: a study protocol
Hanssen et al. 2023 BMJ Open 13(12): e073242

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!